An 84-year-old man with gastric adenocarcinoma and myelodysplastic syndrome who recently completed oral chemotherapy now has three days of fever, mild neutropenia, diarrhea with fecal particles, and tolerable abdominal pain; what is the diagnosis and how should it be managed?

Diagnosis: Neutropenic Enterocolitis (Typhlitis) with Febrile Neutropenia

This 84-year-old patient with recent oral chemotherapy, mild neutropenia, fever for 3 days, diarrhea with particles, and abdominal pain most likely has neutropenic enterocolitis (typhlitis), and requires immediate hospitalization, urgent CT imaging, broad-spectrum antibiotics covering gram-negative and anaerobic organisms, bowel rest, and infectious workup including stool studies for C. difficile and other pathogens.

Clinical Reasoning

This presentation represents a medical emergency. The combination of:

• Recent chemotherapy exposure
• Neutropenia (even if "mild")
• Persistent fever ≥3 days
• Diarrhea with particles (suggesting mucosal sloughing)
• Abdominal pain

...creates a high-risk scenario for chemotherapy-associated bowel syndrome and neutropenic enterocolitis 1, 2.

Key Diagnostic Considerations

Neutropenic enterocolitis is the primary concern because:

• It occurs in severely neutropenic patients after cytotoxic chemotherapy
• The "particles" in diarrhea likely represent sloughed intestinal mucosa
• Fever may be the only sign of serious infection in neutropenic patients 3, 4
• Abdominal pain can be absent or minimal (painless neutropenic enterocolitis has been documented) 5
• This condition carries 1-5% mortality risk and can progress to sepsis and multiorgan failure 1

Important caveat: The patient's myelodysplastic syndrome compounds the neutropenia risk, as MDS itself causes baseline cytopenias and increases infection susceptibility 6.

Immediate Management Algorithm

1. Urgent Hospitalization and Risk Stratification

This patient meets criteria for high-risk febrile neutropenia based on 1:

• Neutropenia with fever
• Abdominal symptoms (cramping, diarrhea)
• Reduced oral intake likely present
• Age >60 years
• Underlying malignancy

2. Diagnostic Workup (Perform Simultaneously, Not Sequentially)

Imaging - URGENT:

• CT abdomen/pelvis with IV contrast to evaluate for:
  • Bowel wall thickening (especially cecum/right colon in typhlitis)
  • Pneumatosis intestinalis
  • Free air (perforation)
  • Toxic megacolon
  • Abscess formation

Laboratory Studies:

• Complete blood count with differential (confirm absolute neutrophil count)
• Comprehensive metabolic panel (assess dehydration, electrolytes, renal function)
• Blood cultures × 2 sets (before antibiotics if possible, but do not delay antibiotics)
• Lactate level (assess for sepsis/bowel ischemia)
• C-reactive protein/procalcitonin

Stool Studies:

• Clostridium difficile toxin PCR (critical - neutropenic patients may not form pseudomembranes) 1
• Bacterial culture and sensitivity
• Viral PCR panel (CMV, norovirus, rotavirus)
• Ova and parasites if epidemiologically relevant

Critical Point: In neutropenic patients, C. difficile colitis may not show typical pseudomembranes endoscopically because pseudomembrane formation requires neutrophils 1. PCR testing and potentially endoscopic biopsy with immunocytochemistry may be needed.

3. Antibiotic Therapy - Initiate Within 1 Hour 4, 7

Empiric broad-spectrum coverage:

First-line monotherapy option:

• Piperacillin-tazobactam 4.5g IV every 6 hours OR
• Cefepime 2g IV every 8 hours OR
• Meropenem 1g IV every 8 hours (if prior resistant organisms or severe sepsis)

Add anaerobic coverage if not using piperacillin-tazobactam:

• Metronidazole 500mg IV every 8 hours

Consider adding gram-positive coverage if:

• Hemodynamic instability
• Suspected catheter-related infection
• Mucositis present
• Previous MRSA colonization

Antifungal prophylaxis 8:

• Consider if prolonged neutropenia expected (>7 days)
• Fluconazole or echinocandin depending on institutional protocols

4. Supportive Care

Bowel Management:

• NPO (nothing by mouth) initially - bowel rest is critical in neutropenic enterocolitis
• IV fluid resuscitation (likely dehydrated from 3 days of diarrhea and fever)
• AVOID loperamide initially until C. difficile is excluded - high-dose loperamide may precipitate toxic megacolon in neutropenic patients with C. difficile 1
• Serial abdominal examinations every 4-6 hours to monitor for peritonitis or toxic dilatation

Growth Factor Support:

• Consider G-CSF (filgrastim) to shorten duration of neutropenia, especially given underlying MDS

Nutritional Support:

• TPN if prolonged bowel rest anticipated

5. Oncology Consultation

Temporarily hold oral chemotherapy until:

• Infection controlled
• Neutropenia resolved
• GI symptoms improved
• Oncologist reassesses risk/benefit 1

Monitoring and Reassessment

Daily monitoring for:

• Worsening abdominal pain or distension (suggests perforation or toxic megacolon)
• Hemodynamic instability
• Worsening neutropenia
• Response to antibiotics (defervescence typically within 48-72 hours if appropriate coverage)

Adjust antibiotics based on:

• Culture results
• Clinical response at 48-72 hours
• Development of new symptoms

Red flags requiring surgical consultation:

• Peritoneal signs
• Free air on imaging
• Clinical deterioration despite appropriate antibiotics
• Toxic megacolon (colon diameter >6cm)

Special Considerations for This Patient

1. Dual malignancy burden: Both gastric adenocarcinoma and MDS increase baseline infection risk and complicate neutropenia management 6

2. Age 84 years: Higher mortality risk from sepsis; lower threshold for ICU transfer if deterioration occurs 2

3. Mucosal barrier injury: Chemotherapy causes direct intestinal mucosal damage beyond just neutropenia, creating a "febrile mucositis" syndrome that allows bacterial translocation even without documented infection 9

4. Fungal considerations: Small bowel fungal overgrowth can mimic bacterial enterocolitis and has been associated with increased perforation risk 1

Common Pitfalls to Avoid

• Delaying antibiotics while awaiting cultures (antibiotics must start within 1 hour) 4, 7
• Using loperamide before excluding C. difficile (risk of toxic megacolon) 1
• Assuming "mild" neutropenia is safe (any neutropenia with fever is high-risk in this context)
• Missing painless neutropenic enterocolitis (pain may be minimal or absent) 5
• Failing to image (CT is essential to assess extent of bowel involvement and exclude perforation)
• Continuing chemotherapy without oncology reassessment (may worsen enterocolitis) 1